Answers are grounded in this paper and cite their sources.
Pilot study evaluates titanium platelet-rich fibrin with drugs on bone regeneration, suggesting benefits for healing.
Objectives: Titanium platelet-rich fibrin (T-PRF) usage as sustained drug delivery system (SDDS) has been recently started. Hence present study aimed to evaluate hard tissue regenerative efficacy of T-PRF clots incorporated with amoxiclav (AMX)/metronidazole (MET)/neem (NE) gels individually in osseous defects created in Wistar rats. Materials and Conclusion: Research results showed that T-PRF can be a SDDS and addition of antibiotics or herbal extract didn't alter the hard tissue healing property of T-PRF and resulted in new bone formation.
No takes yet. Share an insight, caveat, or question.
Gummaluri et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: